The phrase "arteries reducing" is not correct and does not convey a clear meaning in written English.
It may be intended to describe a process related to the narrowing or constriction of arteries, but as it stands, it lacks clarity and context.
Example: "The doctor explained that the condition was caused by arteries reducing in size, leading to decreased blood flow."
Alternatives: "narrowing arteries" or "constricted arteries".
Suggestions included hardening arteries reducing muscle strength.
However, it has been suggested that norepinephrine could constrict cerebral arteries, reducing cerebral blood flow.
You can blame it on the buildup of fatty deposits in your arteries reducing blood flow to your penis.
Over time, hardened plaque narrows the coronary arteries, reducing the flow of oxygen-rich blood to the heart, resulting in CAD [ 2].
Treatment measures include increasing blood oxygen content and dilation of retinal arteries, reducing intraocular pressure immediately through medications (acetazolamide 500 mg i.v or orally, topical beta blocker), ocular massage, and anterior chamber paracentesis, and the use of thrombolytics [ 8].
BH4 supplementation in the presence or absence of NOS inhibition similarly diminished DHE fluorescence only in DE coronary arteries, reducing it to the levels seen in Air arteries and supporting the conclusion that BH4 bioavailability may be depleted after DE exposure.
This chapter highlights that the failure of heart valves or arteries reduces the flow of blood to the body.
Previously, we reported that male M5 muscarinic acetylcholine knockout mice (M5R−/− mice) suffer from a constitutive constriction of cerebral arteries, reduced cerebral blood flow, dendritic atrophy, and short-term memory loss, without necrosis and/or inflammation in the brain.
In the present study, we demonstrated that OVX female M5R−/− mice, in contrast to non-OVX female M5R−/− mice, suffer from a constitutive constriction of cerebral arteries, reduced CBF, dendritic atrophy (Figure 1A), and short-term memory loss (Figure 1C).
68 Pitavastatin at 1 mg/kg in balloon-injured rabbit carotid arteries reduced the risk of restenosis by decreasing neointimal thickening by up to 70%.
Drug-eluting stents (DES) promised to reduce the clinical and economic cost of failed bare metal stents (BMS) by locally delivering a therapeutic agent to the injured artery, reducing or eliminating the development of neointimal hyperplasia and reducing the need for repeat interventions to re-open the obstructed artery.
